Hui Cai1, Xiao-Ou Shu1, Yong-Bing Xiang2, Gong Yang1, Honglan Li2, Bu-Tian Ji3, Jing Gao2, Yu-Tang Gao2, Wei Zheng1. 1. Vanderbilt Epidemiology Center, Department of Medicine and Vanderbilt-Ingram Cancer Center, Nashville, TN. 2. Department of Epidemiology, Cancer Institute of Shanghai Jiao Tong University, Shanghai Cancer Institute, Shanghai, PRC. 3. Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD.
Abstract
OBJECTIVES: To evaluate associations of sleep duration with total mortality and disease-specific mortality in a Chinese population. DESIGN: Prospective study conducted from 1996 (for women)/2002 (for men) to 2010. SETTING: A population-based cohort study in Shanghai, China. INTERVENTION: None. MEASUREMENTS AND RESULTS: A total of 113,138 participants (68,548 women and 44,590 men) of the Shanghai Women's and Men's Health Studies, aged 44-79 y and 40-75 y (women and men, respectively) at sleep duration assessment, were included in the study. In-person interviews were conducted to collect information on sleep duration, socioeconomic status, living conditions, history of chronic disease, participation in regular exercise, and family history of disease. The cohort has been followed using a combination of biannual in-person interviews and record linkages with Shanghai's population-based death registry. Survival status of participants on December 31, 2010 was included as the study outcome. Relative risks were calculated using a Cox proportional model stratified by sex and comorbidity score. There were 4,277 deaths (2,356 among women; 1,921 among men) during a median follow-up time of 7.12 y for women and 6.07 y for men. Among both women and men, sleep duration showed a J-shaped association with total mortality. Hazard ratios (95% confidence intervals) were 1.15 (1.01-1.32), 1.06 (0.94-1.20), 1.17 (1.04-1.32), 1.36 (1.13-1.64), and 2.11 (1.77-2.52) for women and 1.06 (0.90-1.25), 1.07 (0.94-1.23), 1.13 (1.00-1.28), 1.34 (1.10-1.62), and 1.55 (1.29-1.86) for men who slept 4-5, 6, 8, 9, and ≥ 10 h per day, respectively, compared with those who slept 7 h per day. Associations for disease-specific mortality, including cardiovascular disease, stroke, diabetes, and cancer, also generally followed the same J-shaped pattern. The sleep duration-mortality association was more evident among participants with comorbidities, but varied little by sex. CONCLUSION: In our study population of Chinese adults, shorter and longer sleep durations were independently associated with increased risk of mortality. But longer sleep duration had a higher mortality risk of cardiovascular disease and diabetes than short sleep.
OBJECTIVES: To evaluate associations of sleep duration with total mortality and disease-specific mortality in a Chinese population. DESIGN: Prospective study conducted from 1996 (for women)/2002 (for men) to 2010. SETTING: A population-based cohort study in Shanghai, China. INTERVENTION: None. MEASUREMENTS AND RESULTS: A total of 113,138 participants (68,548 women and 44,590 men) of the Shanghai Women's and Men's Health Studies, aged 44-79 y and 40-75 y (women and men, respectively) at sleep duration assessment, were included in the study. In-person interviews were conducted to collect information on sleep duration, socioeconomic status, living conditions, history of chronic disease, participation in regular exercise, and family history of disease. The cohort has been followed using a combination of biannual in-person interviews and record linkages with Shanghai's population-based death registry. Survival status of participants on December 31, 2010 was included as the study outcome. Relative risks were calculated using a Cox proportional model stratified by sex and comorbidity score. There were 4,277 deaths (2,356 among women; 1,921 among men) during a median follow-up time of 7.12 y for women and 6.07 y for men. Among both women and men, sleep duration showed a J-shaped association with total mortality. Hazard ratios (95% confidence intervals) were 1.15 (1.01-1.32), 1.06 (0.94-1.20), 1.17 (1.04-1.32), 1.36 (1.13-1.64), and 2.11 (1.77-2.52) for women and 1.06 (0.90-1.25), 1.07 (0.94-1.23), 1.13 (1.00-1.28), 1.34 (1.10-1.62), and 1.55 (1.29-1.86) for men who slept 4-5, 6, 8, 9, and ≥ 10 h per day, respectively, compared with those who slept 7 h per day. Associations for disease-specific mortality, including cardiovascular disease, stroke, diabetes, and cancer, also generally followed the same J-shaped pattern. The sleep duration-mortality association was more evident among participants with comorbidities, but varied little by sex. CONCLUSION: In our study population of Chinese adults, shorter and longer sleep durations were independently associated with increased risk of mortality. But longer sleep duration had a higher mortality risk of cardiovascular disease and diabetes than short sleep.
Authors: Erico Castro-Costa; Michael E Dewey; Cleusa P Ferri; Elizabeth Uchôa; Josélia O A Firmo; Fábio L Rocha; Martin Prince; Maria Fernanda Lima-Costa; Robert Stewart Journal: J Sleep Res Date: 2010-09-22 Impact factor: 3.981
Authors: James E Gangwisch; Steven B Heymsfield; Bernadette Boden-Albala; Ruud M Buijs; Felix Kreier; Mark G Opler; Thomas G Pickering; Andrew G Rundle; Gary K Zammit; Dolores Malaspina Journal: Sleep Date: 2008-08 Impact factor: 5.849
Authors: Tien-Yu Chen; John W Winkelman; Wei-Chung Mao; Chin-Bin Yeh; San-Yuan Huang; Tung-Wei Kao; Cheryl C H Yang; Terry B J Kuo; Wei-Liang Chen Journal: J Clin Sleep Med Date: 2019-01-15 Impact factor: 4.062
Authors: Hind A Beydoun; May A Beydoun; Xiaoli Chen; Jen Jen Chang; Alyssa A Gamaldo; Shaker M Eid; Alan B Zonderman Journal: Sleep Med Date: 2017-05-29 Impact factor: 3.492
Authors: Shawn D Youngstedt; Eric E Goff; Alexandria M Reynolds; Daniel F Kripke; Michael R Irwin; Richard R Bootzin; Nidha Khan; Girardin Jean-Louis Journal: Sleep Med Rev Date: 2015-08-28 Impact factor: 11.609
Authors: Ryan C Brindle; Matthew R Cribbet; Laura B Samuelsson; Chenlu Gao; Ellen Frank; Robert T Krafty; Julian F Thayer; Daniel J Buysse; Martica H Hall Journal: Psychosom Med Date: 2018 Feb/Mar Impact factor: 4.312